Pioglitazone
Overview
Pioglitazone is a thiazolidinedione antidiabetic, reduces peripheral insulin resistance resulting in a reduction in blood-glucose concentration. Pioglitazone is used, either alone or in combination with metformin or sulphonylureas for the management of type II diabetes mellitus.
Categories
- 18 Hormones and other endocrine drugs and contraceptives
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Pioglitazone's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 15 to 30 mg | 22 (22.5) | 24 hourly | PO | Increased according to response to 45 mg once daily. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Pioglitazone is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Pioglitazone is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Pioglitazone
Back to top
Previous Drug Generic - Next Drug Generic